A cosmetic manufacturing agreement is usually signed in a hurry, at the point when a brand has finally found a factory it likes and wants to start. That is precisely the wrong moment to skim it, because the document governs what happens when something goes wrong, and by then the relationship has changed.
Most disputes in contract manufacturing do not arise from bad faith. They arise from a specification that was never written down precisely, a forecast that was treated as an order, a formula whose ownership was never settled, or a price that was quoted on assumptions nobody recorded.
This article explains the clauses that carry the most practical weight, what to define and what to leave flexible, and what to check before signing. It is a general explanation rather than legal advice, and a contract should be reviewed against the law governing it.
Why the specification clause matters most
The specification is the document that defines what the manufacturer has agreed to supply, and almost every other clause depends on it.
A specification that says a cream is white, smooth and lightly fragranced is not a specification, it is a description. A specification that states the fill weight with a tolerance, the pack and its components, the formula reference with its version, the pH and viscosity ranges with measurement methods, the microbiological limits, the labelling version and the shelf life establishes what conformance means.
The reason this matters commercially is that acceptance and rejection both hinge on conformance. A brand that rejects a batch for being the wrong colour, when the specification said only pale, has no case. A manufacturer that supplies a batch outside an agreed viscosity range, when the range was written down, has one. Writing the specification precisely protects both parties, and it is the single highest-value hour in the whole negotiation.
What an agreement should define
Beyond the specification, a manufacturing agreement normally addresses a defined set of subjects. The table below describes what each is for and where the practical risk sits.
| Clause | What it should establish | Where the risk sits |
|---|---|---|
| Specification | The formula version, pack, tolerances, test methods and limits | Vague wording makes both acceptance and rejection unenforceable |
| Ordering and forecasts | What counts as a binding order and what a forecast is | A forecast treated as an order creates liability for materials the brand did not want |
| Price and adjustment | The basis of the price and how it changes | Raw material volatility without a stated mechanism leads to disputes at renewal |
| Quality and acceptance | The sampling standard, the acceptance criteria and the rejection procedure | Without a defined procedure, rejection becomes a negotiation rather than a right |
| Intellectual property | Ownership of the formula, the artwork, the tooling and the brand marks | Ambiguity here is the most expensive to resolve later |
| Confidentiality | What each party may not disclose or reuse | Needs to survive termination to be useful |
| Liability and indemnity | Who compensates whom in which scenario | Should follow the allocation of responsibility, not the balance of bargaining power |
| Termination and transition | Notice periods, residual obligations and how production transfers | Transition support is often the clause a brand needs most and negotiates last |
Purchase orders, forecasts and binding commitments
The distinction between a forecast and an order is where brands most often incur unintended liability.
Manufacturers buy packaging and raw materials in advance, often with long lead times and their own minimum quantities. To plan, they ask for a rolling forecast. If the agreement treats the forecast as binding, or if the manufacturer is permitted to purchase materials against it, the brand can end up liable for materials it never ordered.
The arrangement that works is explicit about three things. Which document constitutes a binding order, typically a signed purchase order. What portion of a forecast is firm and what is indicative, often expressed as a firm period followed by a planning period. And what happens to materials purchased against a forecast if the brand reduces or cancels, which normally means the brand covers materials already committed and the manufacturer makes reasonable efforts to return or reallocate the rest.
Two related points are worth settling at the same time: the minimum order quantity per SKU and per pack component, and whether the brand may order below the minimum at an agreed premium.
Price, adjustment and raw material volatility
A quoted price is always based on assumptions, and the agreement should record them. The usual assumptions are the formula version, the pack and its decoration, the order quantity, the incoterm and the currency.
Because the formula contains agricultural and petrochemical materials whose prices move, a mechanism for adjustment is normally included. The workable forms are a periodic review at a defined interval, an index-linked formula tied to specified raw materials, or a threshold arrangement where the price changes only if a material moves beyond a defined percentage. Any of these is better than silence, because silence produces a renegotiation at the moment when the brand has least leverage, which is when it is mid-launch.
Currency deserves a specific mention for cross-border supply. A price quoted in one currency with costs incurred in another carries an exposure, and the agreement should state which currency governs and whether the price is adjusted for exchange rate movement.
Quality, acceptance and rejection
Quality clauses should define how conformance is judged, because a batch is either accepted or rejected and the judgement needs a procedure.
The usual basis is a sampling standard, agreed per attribute, with an acceptable quality level that states the maximum proportion of nonconforming units the brand will tolerate. The specification supplies the attribute limits, and the sampling standard supplies the method.
Three practical elements make the clause workable. The inspection period, which is the time the brand has to raise an objection after delivery, because a brand that inspects a batch three months after arrival has no case. The remedy, which should describe whether the manufacturer replaces, credits or refunds, and within what period. And the treatment of a latent defect, which is a defect that could not have been detected on reasonable inspection, since those are usually excluded from the standard inspection period and need their own provision.
Where a brand requires a certificate of analysis, a retention sample or batch records with each delivery, those requirements belong in this clause rather than in an email thread.
Formulas, tooling and intellectual property
Ownership questions in contract manufacturing are simpler to settle before work begins and far more expensive afterwards.
The first question is who owns the formula. If the manufacturer developed it for the brand on a paid development, the brand will normally expect to own it. If it is the manufacturer's stock base with a modification for the brand, ownership of the base normally stays with the manufacturer while the modification may be brand-specific. If the brand brought the formula, ownership is already with the brand, but the manufacturer should be given a defined licence to use it for the brand's orders only.
The second question is what happens to the brand's intellectual property in the manufacturer's hands. The brand marks, the artwork and the packaging designs should be licensed for the purpose of fulfilling the brand's orders, not assigned, and the manufacturer should not be permitted to reference the brand as a customer publicly without consent.
The third question is tooling, where the risk is concentrated in multipart arrangements. Ownership should be stated, along with who stores and maintains the tool, and whether it can be transferred to another manufacturer. A tool designed for one supplier's machine may be unusable elsewhere, which is a reason to establish transferability at the design stage rather than at the end of the relationship.
A related point deserves attention in custom formulations: whether the manufacturer may sell the same or a similar formula to another brand. If the brand's positioning depends on the formula being distinctive, an exclusivity provision limited to a category, a market or a period is worth negotiating explicitly.
Confidentiality and non-compete
Confidentiality clauses are standard, and their value depends on two features.
The first is scope. The definition of confidential information should cover the formula, the specification, the commercial terms, the brand's plans and the technical documentation, and it should cover information that the manufacturer generates about the brand's product as well as information the brand supplies.
The second is survival. A confidentiality clause that ends with the agreement protects nothing that matters, because the useful information is exactly what the manufacturer retains afterwards. A survival period of several years is normal and is worth insisting on.
A non-compete is a different instrument and is rarely appropriate in its broad form. What a brand usually needs is narrower: a restriction on using the brand's formula or a derivative of it for another customer, and a restriction on using the brand's name without consent. A general restriction preventing the manufacturer from working in the same category is normally unacceptable to a manufacturer and often unenforceable, so negotiating for the narrow version is more productive than pushing for the broad one.
Termination and transition
Change is normal in contract manufacturing, and the transition provisions determine how expensive it is.
Two elements should be present. A notice period that gives the manufacturer time to plan and the brand time to arrange a replacement, typically measured in months rather than weeks for a product with long-lead packaging. And an obligation on the manufacturer to cooperate in the transition, which should include supplying the brand with the technical documentation it is entitled to, transferring any tooling the brand owns, and continuing to supply for an agreed period while the replacement is qualified.
The clause a brand most often forgets is the one covering orders in progress. If the agreement is terminated while a batch is in production and packaging has been ordered, the respective liabilities should already be defined rather than argued about during an exit.
What to check before signing
Five checks are worth completing before signing, and each of them is quick if the information is available.
Confirm that the specification attached to the agreement is the one the brand actually approved, including the version of the formula and the pack. Confirm that the price basis states the quantity, the incoterm and the currency. Confirm who owns the formula and the tooling, in writing. Confirm the indemnity arrangement follows the allocation of responsibility, meaning the manufacturer responds to manufacturing defects and the brand to its own formula and claims. And confirm the notice period and the minimum order quantity, because those two numbers govern how much flexibility the brand has.
Frequently asked questions about manufacturing contracts
Do we need a bespoke agreement or is the factory's standard one enough?
A manufacturer's standard agreement is written to protect the manufacturer. It is a reasonable starting point, but the specification, the tooling and formula ownership, the price adjustment mechanism and the forecast treatment are the four areas where a brand should expect to negotiate.
Who owns the formula if the factory developed it for us?
That is what the contract decides. If the brand is paying for the development, owning the result is a reasonable expectation, but it must be stated, since the default under many agreements is that the manufacturer retains it.
Is a forecast binding?
Only if the agreement says so. Establish which document constitutes a binding order and what portion of the forecast is firm, and define what happens to materials purchased against it.
How long should the notice period be?
Long enough to qualify a replacement, which for a product with custom packaging means months rather than weeks. The notice period and the transition support obligation should be read together.
Will you sign our own agreement?
Yes. We work under the brand's agreement or our standard terms, and we provide the specification, ownership statements, batch records and certificates of analysis that the agreement requires.
Next step: write the specification before the contract
If you are preparing to appoint a manufacturer or to renew an agreement, tell us the products involved and we will provide the specification documentation, ownership statements and certificates of analysis that a manufacturing agreement needs to reference. Write to capsulebiotech@163.com, message the right team on WhatsApp: Capsule Series (capsules only) +86 158-7655-5319, Cosmetics Series (serum, hair care, body care, fragrance) +86 158-7655-5319, or use the inquiry form and we will reply within one working day.
Related programmes and guides: firming face cream, vitamin C body wash, and our guides to product liability insurance and minimum order quantities.






